YOR062C Antibody

What is YOR062C and why is it significant for yeast researchers?

YOR062C is a protein of unknown function in Saccharomyces cerevisiae (Baker's yeast) with similarity to Reg1p, a regulatory subunit of the Glc7 PP1 protein phosphatase involved in glucose signaling pathways . The protein's expression is regulated by glucose and the transcription factor Rgt1p, and interestingly, its GFP-fusion protein shows increased expression when exposed to the DNA-damaging agent MMS . YOR062C has a paralog called YKR075C that arose from whole genome duplication .

The significance of YOR062C in research stems from its potential role in connecting glucose signal transduction pathways. According to detailed studies of yeast transcriptome profiling, YOR062C may be part of the regulatory network that integrates different glucose signals operating in multiple pathways . This makes it a valuable target for researchers studying:

• Glucose sensing and response mechanisms in yeast

• The interplay between Snf3/Rgt2-Rgt1 glucose induction pathway and Snf1-Mig1 glucose repression pathway

• Potential roles in DNA damage response mechanisms

• Gene duplication and functional redundancy in yeast evolution

What are the recommended validation methods for YOR062C antibodies?

Proper validation of YOR062C antibodies is crucial for ensuring experimental reliability. A comprehensive validation strategy should include:

• Specificity Testing with Controls:

  • Positive control: Use recombinant YOR062C protein (available at 200μg as part of some antibody packages)

  • Negative control: Use pre-immune serum provided by manufacturers and yeast strains with YOR062C deletions

  • Western blotting with both controls to confirm specific recognition at the expected molecular weight

• Cross-Reactivity Assessment:

  • Test against the paralog YKR075C to ensure signal specificity

  • Evaluate potential cross-reactivity with Reg1p, given their structural similarities

• Application-Specific Validation:

  • For ELISA: Establish standard curves using serial dilutions of recombinant protein

  • For Western blotting: Optimize antibody concentration, incubation time, and detection methods

  • For immunoprecipitation: Verify enrichment of target protein by mass spectrometry

• Functional Validation:

  • Compare antibody detection in wild-type yeast versus strains with altered glucose conditions to confirm physiological relevance

  • Verify if antibody detection patterns correlate with known regulatory patterns of glucose-responsive genes

• Orthogonal Method Verification:

  • Compare results with GFP-fusion protein visualization studies

  • Correlate protein detection with RNA expression data

This multi-faceted validation approach, similar to the comprehensive antigen characterization described for SARS-CoV-2 antibody tests , ensures that the antibody is specific, sensitive, and suitable for the intended research applications.

What are the optimal experimental conditions for using YOR062C antibodies in Western blotting?

For maximum sensitivity and specificity in Western blot detection of YOR062C in yeast samples, follow this optimized protocol:

Sample Preparation:

• Grow yeast to mid-log phase in appropriate media, considering that YOR062C expression is regulated by glucose conditions

• Harvest cells by centrifugation (3,000 × g for 5 minutes)

• Extract proteins using mechanical disruption with glass beads or enzymatic methods with zymolyase

• Use lysis buffer containing: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, and protease inhibitor cocktail

• Clear lysates by centrifugation (14,000 × g for 15 minutes at 4°C)

Gel Electrophoresis and Transfer:

• Load 20-50 μg of total protein per lane on a 10-12% SDS-PAGE gel

• Include positive controls (recombinant YOR062C) and negative controls (yor062cΔ strain)

• Transfer to PVDF membrane at 100V for 1 hour in cold transfer buffer

Antibody Incubation:

• Block membrane with 5% non-fat milk in TBST for 1 hour at room temperature

• Incubate with anti-YOR062C antibody at 1:1000 dilution overnight at 4°C

• Wash 5× with TBST, 5 minutes each

• Incubate with HRP-conjugated secondary antibody (1:5000) for 1 hour at room temperature

• Wash 5× with TBST, 5 minutes each

Detection and Analysis:

• Develop using enhanced chemiluminescence substrate

• Image using digital imaging systems for optimal quantification

• Analyze band intensity using software like ImageJ with normalization to loading controls

• Ensure signal falls within the linear dynamic range by testing different exposure times

This protocol is adapted from successful antibody-based protein detection methodologies used in yeast studies, including those focused on glucose regulation pathways .

How can YOR062C antibodies be used to investigate glucose signaling pathways?

YOR062C antibodies provide valuable tools for investigating glucose signaling networks through multiple experimental approaches:

Expression Analysis:

• Monitor YOR062C protein levels in response to varying glucose concentrations (0.05% to 2%) using Western blotting

• Compare expression patterns in wild-type yeast versus mutants defective in glucose sensing (e.g., Δsnf3, Δrgt2, Δsnf1, Δmig1)

• Quantify temporal dynamics of YOR062C expression during glucose depletion and repletion

Protein-Protein Interactions:

• Perform co-immunoprecipitation with YOR062C antibodies to identify interaction partners

• Investigate potential associations with key components of glucose signaling pathways:

  • Reg1-Glc7 protein phosphatase complex

  • Snf1 kinase pathway components

  • Rgt1 transcription factor and its regulators

Subcellular Localization:

• Use immunofluorescence with YOR062C antibodies to track localization changes in response to glucose availability

• Compare localization patterns with known glucose regulators to identify functional correlations

Chromatin Association:

• Employ chromatin immunoprecipitation (ChIP) to determine if YOR062C associates with regulatory regions of glucose-responsive genes

• Analyze how glucose conditions affect chromatin binding patterns

Functional Studies:

• Combine with genetic approaches (gene knockouts, point mutations) to position YOR062C within the glucose signaling hierarchy

• Correlate YOR062C expression/localization with transcriptional outputs of glucose-regulated genes

This integrated approach leverages the understanding that YOR062C may function at the intersection of the Snf3/Rgt2-Rgt1 glucose induction pathway and the Snf1-Mig1 glucose repression pathway , potentially revealing new insights into how yeast integrates different glucose signals.

What techniques can be used to distinguish between YOR062C and its paralog YKR075C?

Distinguishing between YOR062C and its paralog YKR075C requires specialized experimental approaches, as both proteins likely share structural similarities due to their common evolutionary origin :

Antibody-Based Differentiation:

• Generate epitope-specific antibodies targeting unique regions:

  • Perform sequence alignment to identify divergent peptide sequences

  • Commission custom antibodies against these unique epitopes

  • Validate specificity using recombinant proteins of both paralogs

Genetic Approaches:

• Create single knockout strains (Δyor062c and Δykr075c) and double knockout strain

• Test antibody reactivity against each strain to confirm specificity

• Complement with epitope-tagged versions of each protein for positive control

Detection Strategies:

• Two-dimensional gel electrophoresis followed by Western blotting may separate the paralogs based on slight differences in isoelectric point

• Immunoprecipitation followed by mass spectrometry to identify unique peptides

• Combine with transcriptional analysis using paralog-specific primers to correlate protein and mRNA levels

Functional Differentiation:

• Leverage potential differences in glucose regulation - YOR062C expression is regulated by glucose and Rgt1p

• Examine expression patterns under DNA damage conditions, as YOR062C-GFP is induced by MMS treatment

• Compare subcellular localization patterns using immunofluorescence with validated antibodies

Comparative Analysis:

• Create a scoring matrix comparing reactivity of different commercial antibodies against both paralogs

• Document differential expression patterns under various environmental conditions

• Establish a protocol for researchers to conclusively identify which paralog they are detecting

This systematic approach is crucial when studying proteins with high sequence similarity, as highlighted in advanced antibody characterization methods like those used in SARS-CoV-2 antibody research and the Autonomous Hypermutation yEast surfAce Display (AHEAD) system for antibody generation .

How should researchers interpret experimental data when YOR062C antibody results conflict with other detection methods?

When facing conflicting results between YOR062C antibody detection and alternative methods (such as GFP-fusion visualization or RNA expression data), a systematic troubleshooting approach should be implemented:

Analytical Framework for Resolving Discrepancies:

• Evaluate Antibody Reliability:

  • Revalidate antibody specificity using wild-type and knockout controls

  • Test multiple antibody clones/lots if available

  • Perform peptide competition assays to confirm epitope specificity

• Consider Method-Specific Limitations:

  • GFP fusion: Tag may interfere with protein folding, localization signals, or interactions

  • RNA expression: Post-transcriptional regulation may cause mRNA/protein discrepancies

  • Mass spectrometry: Sample preparation may favor certain protein populations

• Examine Experimental Conditions:

  • Growth conditions: YOR062C is glucose-regulated; ensure consistent media composition

  • Cell cycle stage: Protein expression may vary throughout cell cycle

  • Stress responses: MMS treatment induces YOR062C-GFP

• Technical Considerations:

  • Fixation methods for immunofluorescence can affect epitope accessibility

  • Extraction protocols may preferentially isolate certain protein pools

  • Detection sensitivity differences between methods

• Biological Resolution Strategies:

  • Perform subcellular fractionation followed by Western blotting

  • Use proximity labeling approaches (BioID) to verify localization

  • Correlate with functional assays related to glucose regulation

Data Integration Table Example:

When properly interpreted, seemingly conflicting data can often provide complementary information about protein behavior under different conditions or detection methodologies.

What advanced techniques can be combined with YOR062C antibodies for deeper functional insights?

Integrating YOR062C antibodies with cutting-edge technologies enables more comprehensive understanding of this protein's function in yeast cellular processes:

CRISPR-Cas9 Integration:

• Generate precise mutations in functional domains while maintaining expression

• Create conditionally degradable YOR062C variants for temporal studies

• Introduce epitope tags at the genomic locus for enhanced detection

• Use antibodies to validate expression of CRISPR-modified variants

Proximity-Based Interaction Mapping:

• BioID or TurboID fusion to YOR062C to identify proximal proteins in living cells

• Confirm interactions using co-immunoprecipitation with YOR062C antibodies

• Validate spatial relationships with super-resolution microscopy

Single-Cell Analysis:

• Combine with microfluidics to track YOR062C expression in individual cells

• Correlate with single-cell transcriptomics to identify gene expression patterns

• Use flow cytometry with permeabilized yeast to quantify YOR062C at single-cell level

Engineered Yeast Display Systems:

• Leverage the Autonomous Hypermutation yEast surfAce Display (AHEAD) system to evolve antibodies with enhanced specificity for YOR062C

• Create yeast surface display models expressing YOR062C variants for functional screening

• Use antibodies to validate surface expression levels

Multi-omics Integration:

• Combine antibody-based protein detection with:

  • Phosphoproteomics to map signal transduction pathways

  • Metabolomics to correlate with glucose metabolism changes

  • Chromatin profiling to identify potential transcriptional roles

Computational Modeling:

• Use antibody-derived quantitative data to build predictive models of glucose response

• Apply machine learning to identify patterns in YOR062C behavior across conditions

• Implement active learning approaches similar to those used in antibody-antigen binding prediction

These advanced approaches transform YOR062C antibodies from simple detection tools into probes for comprehensive functional characterization, providing insights into both mechanistic details and system-level understanding of glucose regulation in yeast.

What methodologies are most effective for quantifying YOR062C protein levels?

Accurate quantification of YOR062C protein levels requires selecting appropriate methodologies based on experimental needs:

Western Blot Quantification:

• Use digital imaging systems with CCD cameras for linear dynamic range

• Establish standard curves with recombinant YOR062C protein (available as positive controls)

• Apply normalization to multiple loading controls (e.g., GAPDH, actin, total protein stain)

• Calculate relative expression using densitometry software (ImageJ) with background subtraction

• Include at least three biological replicates for statistical validity

ELISA-Based Approaches:

• Develop sandwich ELISA using two antibodies recognizing different YOR062C epitopes

• Establish standard curves with purified recombinant protein

• Implement 4-parameter logistic regression for accurate concentration determination

• Consider automated plate readers for higher throughput

Advanced Quantitative Platforms:

• Automated capillary immunoassay systems (e.g., Wes, Jess) for higher reproducibility

• Multiplex assays to simultaneously quantify YOR062C and related proteins

• Bead-based flow cytometric assays for increased sensitivity

Mass Spectrometry Methods:

• Selected/Multiple Reaction Monitoring (SRM/MRM) with stable isotope-labeled peptide standards

• Parallel Reaction Monitoring (PRM) for increased specificity

• Data-independent acquisition (DIA) for broader proteome coverage while quantifying YOR062C

Single-Cell Quantification:

• Flow cytometry with permeabilized yeast and fluorescently-labeled antibodies

• Imaging cytometry to correlate expression with morphological features

• Mass cytometry (CyTOF) for multiplexed protein detection at single-cell resolution

Quantification Validation:

• Compare results across multiple methodologies

• Ensure measurements fall within validated linear ranges

• Include spike-in controls to assess recovery efficiency

• Document consistency across different antibody lots

Example Quantification Workflow:

This comprehensive approach ensures reliable quantification of YOR062C across different experimental contexts, enabling robust comparative analyses.

How can researchers effectively use YOR062C antibodies in co-immunoprecipitation experiments?

Co-immunoprecipitation (Co-IP) with YOR062C antibodies is a powerful approach for identifying protein interaction partners within glucose regulation networks. The following optimized protocol enhances success:

Sample Preparation:

• Grow yeast cells in appropriate media (consider both high and low glucose conditions)

• Harvest cells at mid-log phase by centrifugation (3,000 × g, 5 minutes)

• Wash cell pellet twice with cold PBS

• Resuspend in gentle lysis buffer:

  • 50 mM Tris-HCl (pH 7.5)

  • 150 mM NaCl

  • 0.5% NP-40 (or 1% Triton X-100)

  • 1 mM EDTA

  • 5% glycerol

  • Protease inhibitor cocktail

  • Phosphatase inhibitors (if studying phosphorylation)

• Lyse cells using glass bead disruption (8 cycles of 30 seconds with cooling)

• Clear lysate by centrifugation (14,000 × g, 15 minutes, 4°C)

Immunoprecipitation:

• Pre-clear lysate with protein A/G beads (1 hour, 4°C with rotation)

• Prepare antibody-bead complex:

  • Option 1: Incubate YOR062C antibody with protein A/G beads (2 hours, 4°C)

  • Option 2: Use commercial antibody-conjugated magnetic beads for higher purity

• Add pre-cleared lysate to antibody-bead complex

• Incubate overnight at 4°C with gentle rotation

• Wash beads 5× with wash buffer (lysis buffer with reduced detergent)

• Elute bound proteins with:

  • Option 1: SDS sample buffer for direct Western blot analysis

  • Option 2: Mild elution buffer for functional studies (100 mM glycine, pH 2.5)

Controls and Validation:

• Input control: Save aliquot of pre-cleared lysate

• Negative controls:

  • Pre-immune serum or isotype-matched IgG

  • YOR062C-knockout strain lysate

• Specificity control: Peptide competition with immunizing antigen

• Reciprocal Co-IP: Verify interactions by immunoprecipitating with antibodies against identified partners

Analysis:

• Western blot detection for suspected interaction partners

• Mass spectrometry for unbiased identification of all co-precipitated proteins

• Functional validation of identified interactions through genetic approaches

This protocol is designed based on successful co-immunoprecipitation approaches used in yeast protein interaction studies and optimized for proteins involved in glucose regulation pathways like YOR062C .

What are the technical considerations for using YOR062C antibodies in chromatin immunoprecipitation?

Chromatin immunoprecipitation (ChIP) with YOR062C antibodies requires specialized protocols to investigate potential DNA interactions or chromatin association:

Crosslinking and Chromatin Preparation:

• Crosslink yeast cells with 1% formaldehyde for 15 minutes at room temperature

• Quench with 125 mM glycine for 5 minutes

• Wash cells twice with ice-cold TBS

• Lyse cells using glass beads in lysis buffer:

  • 50 mM HEPES-KOH, pH 7.5

  • 140 mM NaCl

  • 1 mM EDTA

  • 1% Triton X-100

  • 0.1% sodium deoxycholate

  • Protease inhibitors

• Sonicate chromatin to generate 200-500 bp fragments

• Verify fragmentation by agarose gel electrophoresis

• Clear lysate by centrifugation

Immunoprecipitation:

• Pre-clear chromatin with protein A/G beads (2 hours, 4°C)

• Incubate pre-cleared chromatin with YOR062C antibody overnight at 4°C

• Add protein A/G beads and incubate for 2-3 hours

• Perform sequential washes with:

  • Low salt buffer (150 mM NaCl)

  • High salt buffer (500 mM NaCl)

  • LiCl buffer (250 mM LiCl)

  • TE buffer

• Elute DNA-protein complexes with elution buffer (1% SDS, 100 mM NaHCO₃)

• Reverse crosslinks at 65°C overnight

• Treat with RNase A and Proteinase K

• Purify DNA using phenol-chloroform extraction or column purification

Critical Controls:

• Input DNA (1-5% of chromatin before immunoprecipitation)

• IgG control (non-specific antibody of same isotype)

• Positive control (antibody against known DNA-binding protein)

• Negative genomic regions (regions not expected to be bound)

• Technical replicates (minimum of three)

Analysis Options:

• ChIP-qPCR: For targeted analysis of specific genomic regions

  • Design primers for promoters of glucose-regulated genes

  • Normalize to input DNA

  • Calculate fold enrichment over IgG control or negative genomic regions

• ChIP-seq: For genome-wide binding profiling

  • Prepare libraries using standard protocols

  • Sequence on appropriate platform (Illumina recommended)

  • Analyze with bioinformatics pipelines like MACS2 for peak calling

Optimization Considerations:

• Antibody amount: Typically 2-5 μg per reaction, but optimize for each lot

• Chromatin amount: 25-50 μg per reaction

• Crosslinking time: May need optimization (10-20 minutes)

• Sonication conditions: Critical for proper fragment size

This protocol is designed specifically for yeast ChIP experiments investigating potential chromatin roles of regulatory proteins like YOR062C in glucose signaling pathways.

How can researchers interpret YOR062C protein expression data in relation to transcriptomic studies?

Integrating YOR062C protein expression data with transcriptomic information requires careful consideration of multiple regulatory layers and appropriate statistical approaches:

Data Collection Strategies:

• Design matched experimental designs:

  • Collect samples for protein and RNA analysis from the same cultures

  • Process in parallel to minimize technical variation

  • Include multiple time points to capture dynamic relationships

• Generate quantitative data:

  • Protein: Western blotting with YOR062C antibodies, normalized to loading controls

  • RNA: RT-qPCR targeting YOR062C mRNA or RNA-seq for genome-wide analysis

Analysis Framework:

• Correlation Analysis:

  • Calculate Pearson's correlation coefficient for linear relationships

  • Use Spearman's rank correlation for non-linear relationships

  • Apply time-lagged correlations to account for temporal offsets between transcription and translation

• Discrepancy Analysis:

  • Investigate post-transcriptional mechanisms:

    • mRNA stability (measure half-life with transcription inhibitors)

    • Translational efficiency (consider ribosome profiling)

    • Protein stability (cycloheximide chase assays)

  • Document condition-specific discrepancies (e.g., glucose levels, stress conditions)

• Multi-omics Integration:

  • Incorporate data on transcription factors regulating YOR062C

  • Consider effects of Rgt1p regulation, which is known to control YOR062C expression

  • Analyze correlations with other glucose-regulated genes

Interpretation Guidelines:

Visualization Approaches:

• Scatter plots of mRNA vs. protein levels with regression analysis

• Time-course plots showing temporal relationships

• Heat maps clustering genes with similar mRNA-protein relationships

• Network diagrams incorporating known regulators

Statistical Considerations:

• Account for technical and biological variability

• Apply appropriate normalization methods for both data types

• Consider batch effects in multi-experiment integration

• Use mixed-effects models for complex experimental designs

This integrated analysis approach provides deeper insights into the regulatory mechanisms controlling YOR062C expression in response to glucose and other environmental conditions.

What are the best practices for troubleshooting when YOR062C antibodies fail to produce expected results?

When YOR062C antibody experiments yield unexpected or negative results, a systematic troubleshooting approach can identify and resolve issues:

Step 1: Antibody Validation Review

• Verify antibody specificity documentation:

  • Check if the antibody was validated against both wild-type and knockout controls

  • Review lot-specific validation data from the manufacturer

• Test antibody functionality:

  • Run a positive control (recombinant YOR062C protein)

  • Confirm antibody hasn't degraded (age, storage conditions)

Step 2: Technical Parameter Assessment

Step 3: Biological Considerations

• Expression conditions:

  • Verify YOR062C is expressed under your experimental conditions

  • Consider glucose concentration effects on expression

• Protein modifications:

  • Post-translational modifications may mask epitopes

  • Test different lysis buffers to preserve or disrupt modifications

• Protein interactions:

  • Binding partners may block antibody access

  • Try more stringent lysis conditions to disrupt interactions

Step 4: Application-Specific Troubleshooting